-+ 0.00%
-+ 0.00%
-+ 0.00%

Cingulate Joins Russell 3000E Index

Benzinga·07/02/2026 12:30:56
Listen to the news

Cingulate Inc. (NASDAQ: CING), a biopharmaceutical company utilizing its proprietary Precision Timed Release™ (PTR™) drug delivery platform technology to build and advance a pipeline of next-generation pharmaceutical products, today announced it has been added to the Russell 3000E® Index.